Sign in

Takahiro Matsuo (Taka), MD

@takamatsuo-id.bsky.social
859 followers 1.4K following 99 posts

Assist Prof @MDAndersonNews | Ortho-ID Fellow @MayoClinicINFD | OncoTx-ID Fellow | Chief Fellow @UT_Infectious | #IDMedEd🇯🇵🇺🇸 | @1min_IDconsult✒️📖

PostsRepliesMedia
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 01/09/2026
【Useful ID Resources #1】 IDMedEd Teaching & Learning Resources 👉Practical teaching and learning resources for ID fellows and educators! idsame.notion.site #IDFellows #IDMedEd @idsainfo.bsky.social
idsame.notion.site
IDSA Medical Education Community of Practice: Teaching & Learning Resources | Notion
The Teaching and Learning Resources Workgroup of the IDSA Medical Education Community of Practice is dedicated to gathering and producing educational materials for ID clinician educators. We are thril...
010
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 10/07/2026
【Defining Success and Failure In Prosthetic Joint Infections: A Meta-epidemiologic Study Toward A Core Outcome Set】 Excited to share our new study! Congrats 🎉 #MayoClinicINFD academic.oup.com/ofid/article... #OrthoID @mdanderson.bsky.social
172
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 09/07/2026
【10-Year Trends in Attributable and Contributable Mortality of Culture-Positive Invasive Aspergillosis in Patients with Hematologic Malignancies】 We are pleased to share our recent article has been accepted in @cidjournal.bsky.social! @utmdanderson.bsky.social academic.oup.com/cid/advance-ar…
051
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/07/2026
Great teamwork on the holiday today! Happy July 4th🇺🇸🎆 @utmdanderson.bsky.social #UT_Infectious #BCMIDFellowship #IDFellow
160
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 20/06/2026
Honored to receive two Teaching Awards of the Year from MD Anderson and Baylor College of Medicine 2025–2026! I’m also delighted to serve as Assistant Program Director of the MDACC ID Fellowship! Thank you very much all mentors, colleagues, fellows!! #IDMedEd #IDFellow @mdanderson.bsky.social
4121
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 09/06/2026
Great learning opportunity for ID fellows/residents! @idsainfo.bsky.social Monday, June 15 at 2pm ET. Register: bit.ly/3RQmozx #IDMedEd #IDFellow #IMResident
041
Reposted by Takahiro Matsuo (Taka), MD
1-min ID consult @1min-idconsult.bsky.social · 06/06/2026
【Splenic Abscess】 In addition to Staph/Strep, it is also important to consider other microorganisms! Level: Intermediate to advanced #IDMedEd #IDFellow #IMResident
041
Reposted by Takahiro Matsuo (Taka), MD
1-min ID consult @1min-idconsult.bsky.social · 06/06/2026
【Encephalitis】Review Lancet 2026 May Binks SNM, Saylor D, Easton A, Thakur KT, Irani SR. Encephalitis. Lancet. 2026 May 16;407(10542):1968-1983. Check our full (10-min) version! spotifycreators-web.app.link/e/Fi0F7eC0K3b pubmed.ncbi.nlm.nih.gov/42134357/
032
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 05/06/2026
Honored to receive an oral presentation award and to deliver an invited educational lecture on bone and joint infections at the 100th Annual Meeting of the Japanese Society of Infectious Diseases. I had a wonderful time reconnecting with many inspiring colleagues and mentors!
150
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 04/06/2026
【The 2026 FIFA World Cup: Communicable disease risks and advice for visitors to Canada, the United States, and Mexico】Travel Med Infect Dis. 2026 May 28 👉Important review on communicable infectious diseases risk! 🇺🇸🇨🇦🇲🇽⚽️🏆 pubmed.ncbi.nlm.nih.gov/42214730/ #IDMedEd #IDFellow #IMResident
152
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 29/01/2026
【The International Immunocompromised Host Society (ICHS) 24th Biennial Symposium】 👉We look forward to meeting you in Houston in May 2026! 👉Great national/international speakers! 👉We will also have an exciting event at NASA Space Center! @mdanderson.bsky.social ichs.org/page-1863395
010
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 18/01/2026
【Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection】@nejm.org, May, 2021 #Keyarticle DATIPO Trial 👉 RCT (🇫🇷, 28 centers), 2011–2015, N=410 👉 6-week therapy failed noninferiority vs 12 weeks (18.1% vs 9.4%) nejm.org/doi/full/10.... #IDMedEd #IDFellow #OrthoID
nejm.org
Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection | NEJM
The management of prosthetic joint infection usually consists of a combination of surgery and antimicrobial therapy. The appropriate duration of antimicrobial therapy for this indication remains un...
000
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 18/01/2026
Thank you very much for having me at such a great educational conference! IDATEN (Infectious Diseases Association for Teaching and Education in Nippon/Japan🇯🇵) We (100+) all learned about bone and joint infections together! #IDMedEd #IDFellow #OrthoID
020
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 20/11/2025
【Houston collaborative ID core curriculum #TXMedCenter】 #3 Neutropenic Fever @mdanderson.bsky.social Definition, History, Management, and Syndromes of Neutropenic Fever, presented by Dr. Yepez! #IDMedEd #IDFellow #IDCoreCurriculum #UT_Infectious #BCMIDFellowship #HMH_IDfellow #MDAndersonNews
020
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 15/11/2025
【Houston collaborative ID core curriculum #TXMedCenter】 #2 Aspergillus @mdanderson.bsky.social Aspergillus infections in hematological malignancy presented by Dr. Kontoyiannis! #IDMedEd #IDFellow #IDCoreCurriculum #UT_Infectious #BCMIDFellowship #HMH_IDfellow @msgerc.bsky.social
150
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 13/11/2025
【ID Core Curriculum】 #1 Eye infections The second part of our #TXMedCenter Houston collaborative ID core curriculum, hosted by @mdanderson.bsky.social has just started! Eye infections presented by Dr. Adachi! #IDMedEd #IDFellow #IDCoreCurriculum #UT_Infectious #BCMIDFellowship #HMH_IDfellow
120
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 24/10/2025
【Consequences of Delaying Surgical Intervention in Patients with Native Joint Septic Arthritis】 Excited to share our article has been published in OFID today and featured as Editor’s Choice! Thank you for mentors and collaborators #MayoClinicINFD! academic.oup.com/ofid/advance... #OrthoID
161
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 24/10/2025
【Towards shorter therapy for candidemia】Lancet ID, Aug 2025 👉Uncomplicated candidemia redefined 👉Controlled source, clinical response, and bloodstream clearance≤5 days=uncomplicated 👉Shorter courses may be safe, RCTs needed www.thelancet.com/journals/lan... @msgerc.bsky.social #IDMedEd #IDFellow
010
Reposted by Takahiro Matsuo (Taka), MD
Luis Ostrosky, MD, FIDSA @drluiso.bsky.social · 22/10/2025
Hot off the press! IC in the ICU link.springer.com/article/10.1... #IDSky
link.springer.com
Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy - Intensive Care Medicine
Background Invasive candidiasis (IC) remains one of the most challenging infections in critical care, contributing significantly to morbidity, prolonged organ support, and mortality among intensive ca...
041
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 22/10/2025
Thank you for coming to our session today! I truly enjoyed the discussion and learned from Q&A! #MayoClinicINFD #OrthoID @idweek.bsky.social #IDWeek2025
030
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 21/10/2025
Just started!!
010
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 21/10/2025
Ready for 2 oral presentations today! (same session) Session Title: Bad to the Bone: News From BJI Session Date: Tuesday October 21, 2025 Session Time: 10:30 AM - 11:45 AM  Location: B401-402 #IDWeek2025 #MayoClinicINFD @idweek.bsky.social #OrthoID #SepticArthritis #NVO
1101
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 20/10/2025
Had a lot of fun at Japan night!#IDWeek2025 Our superstar Dr. Doi is the IDWeek chair!! 🇯🇵 @idweek.bsky.social
090
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 23/08/2025
I was honored to be invited to my former workplace, St. Luke’s in Tokyo, to give a lecture on career development to the residents and fellows! Meeting these young trainees with dreams and passion for the future was truly inspiring! @mdanderson.bsky.social @mayoclinic.org
020
Reposted by Takahiro Matsuo (Taka), MD
paul evan bunce, md @paulbuncemd.bsky.social · 11/07/2025
this is so good! i'd like to staple this article (and graphic) to the wall in every ID trainees' room. these tips for ID case presentations are useful, easy to enact, and high value. nice work @takamatsuo-id.bsky.social et al. #meded #idsky academic.oup.com/ofid/advance...
academic.oup.com
Ten Practical Tips for A Successful Presentation at Infectious Diseases Clinical Case Conference
Abstract. This mini review provides ten practical tips for Infectious Disease (ID) trainees presenting at ID Clinical Case Conferences. These tips, grounde
173
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/07/2025
【Ten Practical Tips for A Successful Presentation at Infectious Diseases Clinical Case Conference】 👉Our mini-review on ID medical education is now out! Many thanks as well to the mentors, editors and reviewers for their valuable feedback! academic.oup.com/ofid/advance... #IDMedEd #IDFellow
1175
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 01/07/2025
Grateful and honored to have trained at #MayoClinicINFD! Learning from such an outstanding team! Thank you for a remarkable year! @mayoclinic.org #Graduation #OrthoIDFellowship
170
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 28/06/2025
I’m thrilled to share that our 2 musculoskeletal infections projects (NVO and septic arthritis) have been accepted for oral presentation! #MayoClinicINFD #OrthoID Huge thanks to my mentors, collaborators, and reviewers🙏 Looking forward to seeing you in Atlanta!! @idweek.bsky.social #IDWeek2025
261
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 18/06/2025
Excited to share our recent article on the “B-index” in invasive pulmonary aspergillosis! 👉In addition to the D-index, blastemia is an important prognostic factor to consider! www.journalofinfection.com/article/S016... @msgerc.bsky.social @mdanderson.bsky.social #Aspergillosis #Bindex
043
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 11/06/2025
Excited to share that our article is amongst the most-cited recent articles in Journal of Antimicrobial Chemotherapy! @mdanderson.bsky.social academic.oup.com/jac/article/... #Fusariosis @msgerc.bsky.social
032
Reposted by Takahiro Matsuo (Taka), MD
Ilan Schwartz @germhuntermd.bsky.social · 10/06/2025
Fungal infections in patients with hematologic malignancies in the pre-triazole era: The dawn of a new era in medical mycology Umut Akova, Rachel Hicklen, Russell E. Lewis, Thomas J. Walsh, Dimitrios P. Kontoyiannis @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.com/article/S119...
Figure. (a-b): Milestones since the dawn of medical mycology. (a) Major events in supportive care of patients with hematologic cancer pertaining to mycology (b) Timeline of introduction of new antifungals.
1127
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/06/2025
Thank you very much #MayoClinicINFD! Such a great time in Rochester, MN✨
040
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/06/2025
【Battle of the Bots: Solving Clinical Cases in Osteoarticular Infections With Large Language Models】Mayo Clin Proc Digit Health. 2025 May We are excited to share our recent article on the use of LLMs in osteoarticular infections! www.mcpdigitalhealth.org/article/S294... #MayoClinicINFD #OrthoID
021
Reposted by Takahiro Matsuo (Taka), MD
Ilan Schwartz @germhuntermd.bsky.social · 27/05/2025
How to approach a patient hospitalized for pneumonia who is not responding to treatment? @drandrekalil.bsky.social and colleagues #IDSky #ICUSky link.springer.com/article/10.1...
Patients should be re-evaluated for response at 48-72 hours after starting therapy with integrated evaluation including clinical, lab, micro, imaging testing. Treatment should be stopped at 7 days. Differential diagnosis for non-responding pneumonia in a hospitalized patient includes delayed recovery, infectious causes (bacterial, fungal, viral, parasitic, resistant organisms, lack of source control, etc), and non-infectious causes. This infographic provides guidance on diagnostic workup for each of these categories.
1165
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 27/05/2025
【Hepatic Mucormycosis】 Excited to share our latest review on hepatic mucormycosis! 👉N=40, 1990-2025 👉histopathology (73%), culture positivity was low (36%) Big congratulations to Hazim for leading the effort! @mdanderson.bsky.social @msgerc.bsky.social www.mdpi.com/2309-608X/11...
042
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 09/05/2025
After a long winter, spring has finally arrived!!😊 #MayoClinicINFD @mayoclinic.org
030
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 04/05/2025
We truly appreciate those who joined #OrthopedicInfectiousDiseases2025 course! 30 in person and 100+ online See you again in 2027! #MayoClinicINFD #MayoOrthoRes
030
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 04/05/2025
#OrthoID jeopardy🎉 #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
120
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【The year in review】Impactful papers in orthopedic infectious diseases 👉Highlight the top 10 important papers in 2024 by Dr. Razonable! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025
011
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Is Corynebacterium striatum the new scourge?】 👉Great summary and discussion on this difficult-to-suppress pathogen by Dr. Tabaja! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
000
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Dental prophylaxis in patients with arthroplasties】 👉Comprehensive summary by Dr. Tabaja! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
000
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Chronic suppression in DAIR】 👉An important discussion on Pros and Cons! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
012
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【When and how do we use dalbavancin?】 Great discussion on dalbavancin! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
021
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Animal bites and Farm frights】 A lot of clinical pearls by Dr. Virk! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
010
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Radiographic diagnosis of osteomyelitis】 👉Important overview on X-ray, CT, MRI, and PET! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
031
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Fracture-related infection】 Comprehensive review by Dr. Suh! #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
001
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 03/05/2025
【Native Joint Septic Arthritis】 Wonderful presentation by our Ryan! @ryankhodadadimd.bsky.social #IDMedEd #IDFellow #OrthopedicInfectiousDiseases2025 #MayoClinicINFD #MayoOrthoRes
020
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 30/04/2025
Ready for this Friday and Saturday! ce.mayo.edu/orthopedic-s... #OrthoID #MayoClinicINFD #MayoMedEd
000
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 21/04/2025
#MusculoskeletalMondays An immunocompetent patient with no significant medical history presents with chronic right ankle wound with sinus tract and a lytic lesion in the distal tibia. What is the diagnosis and most likely pathogen? #OrthoID #MayoClinicINFD
000
Takahiro Matsuo (Taka), MD @takamatsuo-id.bsky.social · 17/04/2025
【TB tenosynovitis】 It was a such a great opportunity to present an important topic at the mycobacterial conference! 👉Although uncommon, let’s consider TB as part of the differentials of tenosynovitis! #OrthoID #MayoClinicINFD #MSISorg #Mycobacterium #IDMedEd #IDFellow
030